21-07-22 - News

Recolony was nominated to participate in the Meet the Venture Leaders Biotech 2022 event

Recolony, a Wyss Zurich project, has been selected out of 60 applications for the Venture Leaders Biotech program and will have the chance to explore Boston and find opportunities for its international growth. Recolony, with nine other startups, will present their solutions to the public on 18 August during the Meet the Venture Leaders Biotech 2022 event.

read more

21-07-22 - Spotlight

Nanoflex has developed a novel catheter that is magnetically steerable and used for rapid and safe stroke treatment

The Wyss Zurich project and ETH spin-​off Nanoflex has developed a magnetically steerable catheter for rapid and safe stroke treatment that no longer requires surgeons to be on site.

read more

12-07-22 - Press Release

Voliro and Constellation Clearsight to bring highly maneuverable drone inspections to U.S. utilities market

Voliro, a startup currently accelerated by Wyss Zurich, has announced a long-term agreement with Constellation Clearsight, a U.S. leader in innovative energy inspection. Clearsight will assist Voliro in further developing its application base, collaborating on market events, and providing direct market feedback on future releases.

read more

31-05-22 - Press Release

A world premiere: for the first time, a human liver was treated in a machine and then successfully transplanted

The multidisciplinary research team of the Wyss Zurich project Liver4Life has succeeded in a treatment attempt that had never been achieved in the history of medicine until now: it treated an originally damaged human liver in a machine for three days outside a body and then implanted the recovered organ into a cancer patient. One year later, the patient is doing well. Read the full press release...

read more

25-05-22 - Press Release

hemotune is winner of the German Innovation Award 2022 in the category Medical Technologies

hemotune AG, a spin-off from ETH Zurich founded in 2017 and currently being accelerated by Wyss Zurich, received the German Innovation Award 2022 in the category Medical Technologies. The German Innovation Award honors products and solutions that distinguish themselves by their user centricity and added value compared to earlier solutions across all industrial sectors. With the HemoSystem, hemotune develops a breakthrough blood purification platform with a first therapy to restore adequate immune response in sepsis-associated immunosuppression. Sepsis is an underserved global health issue leading to around 11 million deaths every year and being one of the most expensive conditions. The award not only highlights the technical solution behind the innovation but also the user-centric design and huge potential impact on society. Read the full press release...

read more

18-05-22 - Press Release

Successful Wyss Zurich model receives further donation of around CHF 100 million

Having funded more than 20 projects, some of which have already been successfully brought to market, Wyss Zurich has established itself in Zurich, a center of innovation. Now it will be receiving another donation of around CHF 100 million from its initiator, Dr. h.c. mult. Hansjörg Wyss, ensuring its operations for another six to eight years. Read the full press release.

read more

17-05-22 - News

Gallatin Award - Swiss Science Celebrates Hansjörg Wyss

More than half a billion Swiss francs have been granted over 10 years to groundbreaking research projects in Switzerland within three different Wyss Centers or Academy in Zurich, Geneva and Bern. This makes entrepreneur and philanthropist Hansjörg Wyss one of the major private donors for Swiss science. Wyss was celebrated in Geneva on May 17, 2022 as the laureate of the 2022 Gallatin Award of the Swiss American Chamber of Commerce. The laudatio was given by Federal Councillor Guy Parmelin. The entire Wyss Zurich family warmly congratulates Hansjörg Wyss on this very merited award! Read the full media release.

read more

16-05-22 - Event

Wyss Zurich participates in the Day of Clinical Research at USZ

On May 19, 2022 Wyss Zurich participates in the annual event of the Directorate of Research and Education of University Hospital Zurich (USZ). This year's topic will be: "New Immunotherapies at the USZ". Participation is free of charge. Take a look at the program and visit us there...

read more

10-05-22 - Event

#SUD22: Wyss Zurich at Startup Days in Berne on May 19, 2022

Wyss Zurich will be present at #SUD22. Together with our projects hemotune, MUVON, Nanoflex, and Voliro you will find us at our booth in the Exhibition & Exchange Area. Visit us on May 19, 2022 in Berne and exchange ideas one-to-one with our projects. In addition, MUVON Therapeutics AG has reached the semi-finals and will be pitching live in the Healthtech section. Also, discover more than 100 brilliant speakers and the 50 insightful sessions divided into four tracks: Inspiration, Learning, Scaling and Pitching. You'll expand your skills, think outside the box, and meet new like-minded startup enthusiasts. If you don't have a ticket yet, you can still order it now:

read more

07-05-22 - Media Coverage

Badische Neueste Nachrichten - World-renowned robotics researcher Roland Siegwart honored with Ernst-Blickle-Award

Congratulations to our Wyss Zurich Founding Co-Director Roland Siegwart! Robots are ubiquitous. With prize money of 100,000 euros, the SEW Foundation in Bruchsal is honoring a robotics researcher who has made a decisive contribution to their development: Roland Siegwart, professor at the Institute of Robotics and Intelligent Systems at ETH Zurich, received the award for his contributions to the development and control of robotic systems. He had also rendered outstanding services in turning research results into marketable products. Numerous start-ups can be traced back to his initiative. The honoree dedicated the €100,000 prize to his young scientists. "They are the ones who carry our visions out into the world," Siegwart thanked them after the award ceremony in the Fürstensaal of Bruchsal Castle.

read more